These companies have licensed the patents from one side or the other even as the patents are being hotly disputed—which might give a sense of how eager companies are to move forward on CRISPR therapies.
The dispute originates in research done by the Broad Institute’s Feng Zhang and UC Berkeley’s Jennifer Doudna, who was also collaborating with Emmanuelle Charpentier, then of the University of Vienna.
In a statement about the appeal, Edward Penhoet, a special adviser on CRISPR to the UC president and UC Berkeley chancellor, said, “Ultimately, we expect to establish definitively that the team led by Jennifer Doudna and Emmanuelle Charpentier was the first to engineer CRISPR-Cas9 for use in all types of environments, including in non-cellular settings and within plant, animal and even human cells.” The Broad countered, “Given that the facts have not changed, we expect the outcome will once again be the same.” If UC wins the appeal, the court could kick it back to the patent office to make another decision on interference.
When a person lives in poverty, a growing body of research suggests the limbic system is constantly sending fear and stress messages to the prefrontal cortex, which overloads its ability to solve problems, set goals, and complete tasks in the most efficient ways.
Marine Le Pen, the candidate of the far-right National Front, is through to the second round of the French presidential election, where she will face Emmanuel Macron, the independent, who won Sunday's first round with 23.7 percent of the vote.